Goetz MP, O'Shaughnessy J, Sledge Jr., et al. The benefit of abemaciclib in prognostic subgroups: An exploratory analysis of combined data from the MONARCH 2 and 3 studies. SABCS 2017, GS6-02.
Beter beeld van pancreascarcinoom dankzij FF-OCT
apr 2017 | Chirurgie, Maag-darm-leveroncologie